Zheng Quan Zhi Xing·2025-03-28 15:02Core Viewpoint - The independent director of Beijing Chunli Zhengda Medical Device Co., Ltd. reports on the fulfillment of duties in 2024, emphasizing adherence to laws and regulations while maintaining the interests of all shareholders, particularly minority shareholders [1][2][3]. Independent Director's Basic Information - The board consists of eight directors, with three independent directors, meeting legal requirements [3]. - The independent director has a strong professional background, including experience in various companies and membership in accounting associations [2]. Independent Director's Performance in 2024 - Attendance at meetings: The independent director attended 3 shareholder meetings and 14 board meetings, actively participating in discussions and voting in favor of all proposals [4]. - Communication with company personnel was maintained to understand operational and financial conditions [4]. Key Focus Areas of Independent Director - Related party transactions were conducted fairly and did not harm the interests of the company or shareholders [5]. - No external guarantees or fund occupation occurred during the reporting period [5]. - The use of raised funds was in line with project requirements, ensuring shareholder interests were protected [5]. - The independent director approved the remuneration plan for directors and senior management, ensuring compliance with regulations and industry standards [6]. - The company disclosed its annual performance report in accordance with relevant regulations, ensuring transparency [6]. - The independent director supported the reappointment of the auditing firm, affirming its qualifications and experience [6]. - A cash dividend of RMB 0.49 per share was proposed, totaling RMB 18.75 million, which is 15% of the net profit attributable to ordinary shareholders [6]. - The company and shareholders adhered to commitments regarding competition and related transactions [7]. - Information disclosure was timely and accurate, reflecting the company's operational status [9]. - Internal controls were assessed as effective, with no significant deficiencies reported [10]. - The board and its committees operated in compliance with legal and regulatory requirements, ensuring effective governance [10]. Overall Evaluation and Suggestions - The independent director expresses gratitude for the support received and emphasizes the commitment to uphold shareholder interests while promoting the company's sustainable development [10].